Swedish cash boost cuts waiting lists:
This article was originally published in Clinica
Executive Summary
The Swedish government last week confirmed a cash injection of SKr 3.75 billion ($364 million) for the health service, in accordance with its cross party agreement negotiated in June 2000. Health minister Lars Engqvist insisted, that the money, which was aimed at reducing waiting lists, was already having the desired effect. "The most convincing example is the increase in the number of cataract operations, from 39,500 in 1994 to 72,000 last year," he said. He added that the number of hip operations had also increased, from 12,000 in 1994 to 16,000 in 2000.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.